UK service provider Source BioScience has purchased two Illumina Genome Analyzer IIx systems and plans to bring the firm's HiSeq 2000 technology in house later this year, the company said this week.
Source BioScience said it has invested a total of £700,000 ($1.13 million) in the two systems and ancillary equipment, which will be housed in its Nottingham facility. It has had an Illumina GA since 2008.
In addition to the instrument purchase, Illumina has designated Source BioScience as a CSPro-certified service provider for its sequencing technology.
Source BioScience provides diagnostic and screening services to the healthcare community, and genetic analysis and biomolecular tools to life science researchers as well as pharma and biotech companies.
The company, which is headquartered in Nottingham and has other labs in London, Cambridge, Oxford, and Dublin, offers both Sanger and next-generation DNA sequencing services and bioinformatics support.
In 2007, Geneservice, a contract research service provider based in Cambridge, became part of Source BioScience.